Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ZSB | 13.62 | N/A | N/A |
| USCF Sustainable Battery Metals Stgy Fd | |||
| XRLV | 54.80 | -0.50 | -0.91% |
| Invesco S&P 500® ex-Rate Snsv LowVol ETF | |||
| BFOR | 73.95 | -1.23 | -1.64% |
| Barron's 400 ETF | |||
| IYJ | 138.08 | -2.68 | -1.90% |
| iShares US Industrials ETF | |||
| CXSE | 34.10 | -0.72 | -2.07% |
| WisdomTree China ex-State-Owd Entpr ETF | |||
A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.
| Ticker / NAME | Correlation To CLYYF | 1D Price Change % | ||
|---|---|---|---|---|
| CLYYF | 100% | N/A | ||
| ELVAF - CLYYF | 47% Loosely correlated | N/A | ||
| REPL - CLYYF | 35% Loosely correlated | -1.06% | ||
| HLVX - CLYYF | 29% Poorly correlated | -3.65% | ||
| IBIO - CLYYF | 23% Poorly correlated | -9.89% | ||
| ATHE - CLYYF | 22% Poorly correlated | -4.14% | ||
More | ||||